查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1424066

先进医疗製药(ATMP)CDMO市场、份额、规模、趋势、行业分析报告：按产品、阶段、适应症、地区、细分市场预测，2024-2032年

Advanced Therapy Medicinal Products CDMO Market Share, Size, Trends, Industry Analysis Report, By Product (Gene Therapy, Cell Therapy, Tissue Engineered, Others); By Phase; By Indication; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，到 2032 年，全球先进医疗製药 (ATMP) CDMO 市场规模预计将达到 262.7 亿美元。 该报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

随着人群中多种疾病的发展，慢性健康问题现在可以用普通药物治疗，研究人员和政府机构被迫投资于遗传医学以及细胞和组织疗法。 这种持续的趋势为製药公司创新新疗法创造了有利的环境，并推动了对拥有必要基础设施来开发、测试和製造新疗法的组织的需求。我们需要合约组织（CDMO）的支持。

政府监管製药业的举措不断增多，对先进医疗製药 (ATMP) CDMO 市场的成长机会产生了积极影响。 2023 年 9 月，英国 CDMO Rentschler Biopharma SE 获得药品和保健品监管机构的批准，可以开发和供应用于生物加工和基因治疗（包括 cGMP 生产）的腺相关病毒载体（AAV）。

旨在扩大治疗健康问题的研发活动的策略合作和伙伴关係的新兴市场正在对 ATMP CDMO 市场产生积极影响。 Reprocell 将与 Histocell 合作生产源自间质干细胞的先进疗法和药物。

细胞治疗和基因治疗生产显示出积极的市场前景。 根据《基因、细胞和RNA治疗格局报告》，2023年第三季度，有27种基因疗法、26种RNA疗法和65种非基因改造细胞疗法被批准用于临床。 第三季处于1期临床试验的基因治疗药物总数较第一季成长7%。 这一趋势显示了对先进医疗药物生产的潜在需求，从而增加了未来几年对 CDMO 的需求。

组织工程产业在市场上势头强劲。 其驱动力在于其在组织替换、修復和再生方面的深入影响，用于治疗与皮肤、心臟、肝臟和肺组织相关的健康问题。 与组织工程治疗开发相关的研究活动的增加预计将推动先进疗法的 CDMO 市场。

先进医疗药品 (ATMP) CDMO 市场报告亮点

由于与基因治疗相关的临床试验的增加，预计基因治疗领域在未来几年将有最高的成长。

由于治疗开发数量的增加，第一期市场占据了最大的收入份额。

由于癌症患者数量增加且形式多样，肿瘤领域所占份额最大。

由于细胞和基因疗法投资的增加，预计亚太地区将在预测期内实现最快的成长。

目录

第 1 章简介

第 2 章执行摘要

第 3 章研究方法

第 4 章全球先进医疗药品 (ATMP) CDMO 市场洞察

  • 先进医疗药品 (ATMP) CDMO 市场 - 阶段快照
  • 先进医疗药品 (ATMP) CDMO 市场动态
    • 促进因素和机会
      • 生物技术中基于细胞和基因的疗法的兴起
      • CDMO产能高
    • 抑制因素和挑战
      • ATMP 生产相关的技能短缺可能会阻碍市场成长
  • PESTEL 分析
  • 先进医药CDMO市场阶段趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第 5 章按适应症划分的全球先进医疗製药 (ATMP) CDMO 市场

  • 主要发现
  • 简介
  • 肿瘤学
  • 心臟病学
  • 中枢神经系统
  • 肌肉骨骼系统
  • 传染病
  • 皮肤科
  • 内分泌、新陈代谢、遗传学
  • 免疫学和炎症
  • 眼科
  • 血液学
  • 胃肠病学
  • 其他

第 6 章按产品划分的全球先进医疗製药 (ATMP) CDMO 市场

  • 主要发现
  • 简介
  • 细胞疗法
  • 基因治疗

第 7 章全球先进医疗製药 (ATMP) CDMO 市场（按阶段）

  • 主要发现
  • 简介
  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

第 8 章按地区划分的全球先进医疗药品 (ATMP) CDMO 市场

  • 主要发现
  • 简介
    • 2019-2032 年先进医疗药品 (ATMP) CDMO 市场评估（按地区）
  • 先进医疗药品 (ATMP) CDMO 市场 - 北美
    • 北美：先进医疗製药 (ATMP) CDMO 市场，按适应症划分，2019-2032 年
    • 北美：2019-2032 年先进医疗製药 (ATMP) CDMO 市场（按阶段）
    • 北美：先进医疗製药 (ATMP) CDMO 市场（按产品），2019-2032 年
    • 先进医疗药品 (ATMP) CDMO 市场 - 美国
    • 先进医疗药品 (ATMP) CDMO 市场 - 加拿大
  • 先进医疗药品 (ATMP) CDMO 市场 - 欧洲
    • 欧洲：2019-2032 年先进医疗製药 (ATMP) CDMO 市场（按适应症）
    • 欧洲：2019-2032 年先进医疗製药 (ATMP) CDMO 市场（按阶段）
    • 欧洲：先进医疗製药 (ATMP) CDMO 市场（按产品），2019-2032 年
    • 先进医疗药品 (ATMP) CDMO 市场 - 英国
    • 先进医疗药品 (ATMP) CDMO 市场 - 法国
    • 先进医疗药品 (ATMP) CDMO 市场 - 德国
    • 先进医疗药品 (ATMP) CDMO 市场 - 义大利
    • 先进医疗药品 (ATMP) CDMO 市场 - 西班牙
    • 先进医疗药品 (ATMP) CDMO 市场 - 荷兰
    • 先进医疗药品 (ATMP) CDMO 市场 - 俄罗斯
  • 先进医疗药品 (ATMP) CDMO 市场 - 亚太地区
    • 亚太地区：2019-2032 年先进医疗製药 (ATMP) CDMO 市场（按适应症）
    • 亚太地区：2019-2032 年先进医疗製药 (ATMP) CDMO 市场（按阶段）
    • 亚太地区：2019-2032 年先进医疗製药 (ATMP) CDMO 市场（按产品）
    • 先进医疗药品 (ATMP) CDMO 市场 - 中国
    • 先进医疗药品 (ATMP) CDMO 市场 - 印度
    • 先进医疗药品 (ATMP) CDMO 市场 - 马来西亚
    • 先进医疗用药 CDMO 市场 - 日本
    • 先进医疗药品 (ATMP) CDMO 市场 - 印尼
    • 先进医疗药品 (ATMP) CDMO 市场 - 韩国
  • 先进医疗药品 (ATMP) CDMO 市场 - 中东和非洲
    • 中东和非洲：先进医疗药品 (ATMP) CDMO 市场，按适应症划分，2019-2032 年
    • 中东和非洲：2019-2032 年先进医疗药品 (ATMP) CDMO 市场（按阶段）
    • 中东和非洲：先进医疗製药 (ATMP) CDMO 市场（按产品），2019-2032 年
    • 先进医疗药品 (ATMP) CDMO 市场 - 沙乌地阿拉伯
    • 先进医疗药品 (ATMP) CDMO 市场 - 阿拉伯联合大公国
    • 先进医疗药品 (ATMP) CDMO 市场 - 以色列
    • 先进医疗药品 (ATMP) CDMO 市场 - 南非
  • 先进医疗药品 (ATMP) CDMO 市场 - 拉丁美洲
    • 拉丁美洲：先进医疗製药 (ATMP) CDMO 市场，按适应症划分，2019-2032 年
    • 拉丁美洲：2019-2032 年先进医疗药品 (ATMP) CDMO 市场（按阶段）
    • 拉丁美洲：先进医疗製药 (ATMP) CDMO 市场（按产品），2019-2032 年
    • 先进医疗药品 (ATMP) CDMO 市场 - 墨西哥
    • 先进医疗药品 (ATMP) CDMO 市场 - 巴西
    • 先进医疗药品 (ATMP) CDMO 市场 - 阿根廷

第 9 章竞争态势

  • 扩张与收购分析
    • 扩大
    • 收购
  • 伙伴关係/协作/协议/揭露

第 10 章公司简介

  • AGC Biologics（Switzerland）
  • Bio Elpida（France）
  • BlueReg（France）
  • Catalent（US）
  • Celonic（Switzerland）
  • CGT Catapult（UK）
  • Lonza（Switzerland）
  • Medicine Patheon（US）
  • Minaris Regenerative（US）
  • Rentschler Biopharma SE（US）
  • WuXi Advanced Therapies（US）
Product Code: PM4326

The global advanced therapy medicinal products CDMO market size is expected to reach USD 26.27 billion by 2032, according to a new study by Polaris Market Research. The report "Advanced Therapy Medicinal Products CDMO Market Share, Size, Trends, Industry Analysis Report, By Product (Gene Therapy, Cell Therapy, Tissue Engineered, Others); By Phase; By Indication; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The evolution of numerous diseases among the population and the ability to cure chronic health issues with the prevailing medicines is compelling researchers and government institutions to invest in genetic medicine and cell and tissue therapies. This ongoing trend is facilitating a compatible environment for pharmaceutical companies to innovate new therapies, driving the need for organizations that have the required infrastructure for the development, testing, and manufacturing of new therapies, necessitating the assistance of contract development and manufacturing organizations (CDMO).

The rising government initiatives to regulate the pharmaceutical industry are showing a positive impact on the advanced therapy medicinal products CDMO market growth opportunities. In September 2023, UK CDMO Rentschler Biopharma SE received approval to develop and supply adeno-associated virus vectors (AAV) for gene therapy, including bioprocessing and cGMP production, from the Medicines & Healthcare Products Regulatory Agency.

The growing strategic collaborations and partnerships to expand the research and development activities towards treating health problems are positively influencing the ATMP CDMO market. With the Histocell partnership, Reprocell will produce advanced therapies and medicinal products generated from mesenchymal stem cells.

Cell and gene therapy production is showing a positive outlook in the market. According to the Gene, Cell, & RNA Therapy Landscape Report, in Q3 2023, 27 gene therapies, 26 RNA therapies, and 65 non-genetically modified cell therapies, received approval for clinical use. The total number of gene therapies in phase 1 Q3 registered growth by 7% compared to Q1. This trend is demonstrating the potential demand to produce advanced therapeutic medicinal products, boosting the need for CDMO in the coming years.

The tissue engineering industry is gaining momentum in the marketplace, driven by its profound scope in the replacement, repair, and regeneration of tissues, which are used to cure skin, heart, liver, and lung tissue-related health problems. The rising research activities on the development of tissue engineering therapies are expected to drive the advanced therapy medicinal products CDMO market.

Advanced Therapy Medicinal Products CDMO Market Report Highlights

Gene therapy segment is anticipated to witness the highest growth in the coming years due to the increasing clinical trials on gene therapies.

Phase I segment accounted for the largest revenue share, owing to the rise in number of therapeutic developments.

Oncology segment held the largest share, due to the rising number of cancer patients and its varied forms

Asia pacific is projected to register the fastest growth during the forecast period, attributable to the growing investments in cell and gene therapies.

The global players include AGC Biologics, Bio Elpida, BlueReg, Catalent, Celonic, CGT Catapult, Lonza, Medicine Patheon, & Minaris Regenerative.

Polaris Market Research has segmented the advanced therapy medicinal products CDMO market report based on product, phase, indication and region:

Advanced Therapy Medicinal Products CDMO, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Cell Therapy
  • Gene Therapy

Advanced Therapy Medicinal Products CDMO, Phase Outlook (Revenue - USD Billion, 2019 - 2032)

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Advanced Therapy Medicinal Products CDMO, Indication Outlook (Revenue - USD Billion, 2019 - 2032)

  • Oncology
  • Cardiology
  • Central nervous system
  • Musculoskeletal
  • Infectious disease
  • Dermatology
  • Endocrine, metabolic, genetic
  • Immunology & inflammation
  • Ophthalmology
  • Hematology
  • Gastroenterology
  • Others

Advanced Therapy Medicinal Products CDMO, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Advanced Therapy Medicinal Products CDMO Market Insights

  • 4.1. Advanced Therapy Medicinal Products CDMO Market - Phase Snapshot
  • 4.2. Advanced Therapy Medicinal Products CDMO Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. The rising cell and gene-based therapies in biotechnology
      • 4.2.1.2. The higher production capability of CDMOs
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. The talent shortage pertaining to ATMP production is likely to impede market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Advanced Therapy Medicinal Products CDMO Market Phase Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Advanced Therapy Medicinal Products CDMO Market, by Indication

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • 5.3. Oncology
    • 5.3.1. Global Advanced Therapy Medicinal Products CDMO Market, by Oncology, by Region, 2019-2032 (USD Billion)
  • 5.4. Cardiology
    • 5.4.1. Global Advanced Therapy Medicinal Products CDMO Market, by Cardiology, by Region, 2019-2032 (USD Billion)
  • 5.5. Central nervous system
    • 5.5.1. Global Advanced Therapy Medicinal Products CDMO Market, by Central nervous system, by Region, 2019-2032 (USD Billion)
  • 5.6. Musculoskeletal
    • 5.6.1. Global Advanced Therapy Medicinal Products CDMO Market, by Musculoskeletal, by Region, 2019-2032 (USD Billion)
  • 5.7. Infectious disease
    • 5.7.1. Global Advanced Therapy Medicinal Products CDMO Market, by Infectious disease, by Region, 2019-2032 (USD Billion)
  • 5.8. Dermatology
    • 5.8.1. Global Advanced Therapy Medicinal Products CDMO Market, by Dermatology, by Region, 2019-2032 (USD Billion)
  • 5.3. Endocrine, metabolic, genetic
    • 5.3.1. Global Advanced Therapy Medicinal Products CDMO Market, by Endocrine, metabolic, genetic, by Region, 2019-2032 (USD Billion)
  • 5.4. Immunology & inflammation
    • 5.4.1. Global Advanced Therapy Medicinal Products CDMO Market, by Immunology & inflammation, by Region, 2019-2032 (USD Billion)
  • 5.5. Ophthalmology
    • 5.5.1. Global Advanced Therapy Medicinal Products CDMO Market, by Ophthalmology, by Region, 2019-2032 (USD Billion)
  • 5.6. Hematology
    • 5.6.1. Global Advanced Therapy Medicinal Products CDMO Market, by Hematology, by Region, 2019-2032 (USD Billion)
  • 5.7. Gastroenterology
    • 5.7.1. Global Advanced Therapy Medicinal Products CDMO Market, by Gastroenterology, by Region, 2019-2032 (USD Billion)
  • 5.8. Others
    • 5.8.1. Global Advanced Therapy Medicinal Products CDMO Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Advanced Therapy Medicinal Products CDMO Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • 6.3. Cell Therapy
    • 6.3.1. Global Advanced Therapy Medicinal Products CDMO Market, by Cell Therapy, by Region, 2019-2032 (USD Billion)
  • 6.4. Gene Therapy
    • 6.4.1. Global Advanced Therapy Medicinal Products CDMO Market, by Gene Therapy, by Region, 2019-2032 (USD Billion)

7. Global Advanced Therapy Medicinal Products CDMO Market, by Phase

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • 7.3. Phase I
    • 7.3.1. Global Advanced Therapy Medicinal Products CDMO Market, by Phase I, By Region, 2019-2032 (USD Billion)
  • 7.4. Phase II
    • 7.4.1. Global Advanced Therapy Medicinal Products CDMO Market, by Phase II, By Region, 2019-2032 (USD Billion)
  • 7.5. Phase III
    • 7.5.1. Global Advanced Therapy Medicinal Products CDMO Market, by Phase III, By Region, 2019-2032 (USD Billion)
  • 7.6. Phase IV
    • 7.6.1. Global Advanced Therapy Medicinal Products CDMO Market, by Phase IV, By Region, 2019-2032 (USD Billion)

8. Global Advanced Therapy Medicinal Products CDMO Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Advanced Therapy Medicinal Products CDMO Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Advanced Therapy Medicinal Products CDMO Market - North America
    • 8.3.1. North America: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
    • 8.3.2. North America: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
    • 8.3.3. North America: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.3.4. Advanced Therapy Medicinal Products CDMO Market - U.S.
      • 8.3.4.1. U.S.: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.3.5. Advanced Therapy Medicinal Products CDMO Market - Canada
      • 8.3.5.1. Canada: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • 8.4. Advanced Therapy Medicinal Products CDMO Market - Europe
    • 8.4.1. Europe: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.4.4. Advanced Therapy Medicinal Products CDMO Market - UK
      • 8.4.4.1. UK: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.4.5. Advanced Therapy Medicinal Products CDMO Market - France
      • 8.4.5.1. France: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.4.6. Advanced Therapy Medicinal Products CDMO Market - Germany
      • 8.4.6.1. Germany: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.4.7. Advanced Therapy Medicinal Products CDMO Market - Italy
      • 8.4.7.1. Italy: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.4.8. Advanced Therapy Medicinal Products CDMO Market - Spain
      • 8.4.8.1. Spain: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.4.9. Advanced Therapy Medicinal Products CDMO Market - Netherlands
      • 8.4.9.1. Netherlands: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.4.10. Advanced Therapy Medicinal Products CDMO Market - Russia
      • 8.4.10.1. Russia: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • 8.5. Advanced Therapy Medicinal Products CDMO Market - Asia Pacific
    • 8.5.1. Asia Pacific: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.5.4. Advanced Therapy Medicinal Products CDMO Market - China
      • 8.5.4.1. China: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.5.5. Advanced Therapy Medicinal Products CDMO Market - India
      • 8.5.5.1. India: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.5.6. Advanced Therapy Medicinal Products CDMO Market - Malaysia
      • 8.5.6.1. Malaysia: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.5.7. Advanced Therapy Medicinal Products CDMO Market - Japan
      • 8.5.7.1. Japan: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.5.8. Advanced Therapy Medicinal Products CDMO Market - Indonesia
      • 8.5.8.1. Indonesia: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.5.9. Advanced Therapy Medicinal Products CDMO Market - South Korea
      • 8.5.9.1. South Korea: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • 8.6. Advanced Therapy Medicinal Products CDMO Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.6.4. Advanced Therapy Medicinal Products CDMO Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.6.5. Advanced Therapy Medicinal Products CDMO Market - UAE
      • 8.6.5.1. UAE: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.6.6. Advanced Therapy Medicinal Products CDMO Market - Israel
      • 8.6.6.1. Israel: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.6.7. Advanced Therapy Medicinal Products CDMO Market - South Africa
      • 8.6.7.1. South Africa: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • 8.7. Advanced Therapy Medicinal Products CDMO Market - Latin America
    • 8.7.1. Latin America: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.7.4. Advanced Therapy Medicinal Products CDMO Market - Mexico
      • 8.7.4.1. Mexico: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.7.5. Advanced Therapy Medicinal Products CDMO Market - Brazil
      • 8.7.5.1. Brazil: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.7.6. Advanced Therapy Medicinal Products CDMO Market - Argentina
      • 8.7.6.1. Argentina: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AGC Biologics (Switzerland)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bio Elpida (France)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. BlueReg (France)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Catalent (US)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Celonic (Switzerland)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. CGT Catapult (UK)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Lonza (Switzerland)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Medicine Patheon (US)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Minaris Regenerative (US)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Rentschler Biopharma SE (US)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. WuXi Advanced Therapies (US)
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development

List of Tables

  • Table 1 Global Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 2 Global Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 3 Global Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 4 Advanced Therapy Medicinal Products CDMO Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 6 North America: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 7 North America: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 8 U.S.: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 9 U.S.: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 10 U.S.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 11 Canada: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 12 Canada: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 13 Canada: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 14 Europe: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 15 Europe: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 16 Europe: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 17 UK: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 18 UK: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 19 UK: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 20 France: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 21 France: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 22 France: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 23 Germany: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 24 Germany: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 25 Germany: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 26 Italy: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 27 Italy: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 28 Italy: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 29 Spain: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 30 Spain: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 31 Spain: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 35 Russia: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 36 Russia: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 37 Russia: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 41 China: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 42 China: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 43 China: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 44 India: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 45 India: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 46 India: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 50 Japan: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 51 Japan: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 52 Japan: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 56 South Korea: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 57 South Korea: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 58 South Korea: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 65 UAE: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 66 UAE: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 67 UAE: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 68 Israel: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 69 Israel: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 70 Israel: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 71 South Africa: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 72 South Africa: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 73 South Africa: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 74 Latin America: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 75 Latin America: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 76 Latin America: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 77 Mexico: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 78 Mexico: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 79 Mexico: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 80 Brazil: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 81 Brazil: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 82 Brazil: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 83 Argentina: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 84 Argentina: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 85 Argentina: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Advanced Therapy Medicinal Products CDMO Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Advanced Therapy Medicinal Products CDMO Market, by Product, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Indication
  • Figure 9. Global Advanced Therapy Medicinal Products CDMO Market, by Indication, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Phase
  • Figure 11. Global Advanced Therapy Medicinal Products CDMO Market, by Phase, 2022 & 2032 (USD Billion)
  • Figure 12. Advanced Therapy Medicinal Products CDMO Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Advanced Therapy Medicinal Products CDMO Market